TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.
1
Funding Rounds
$32.5m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
The company Enara Bio has raised a total of $32.5m in funding over 1 rounds.